¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Proceedings. Clinical Spinal Cord Injury Conference."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • birth injury
    ºÐ¸¸¼Õ»ó, Ãâ»ê¼Õ»ó
  • blast injury
    ÆøÇ³¼Õ»ó
  • blunt injury
    ¹«µò¼Õ»ó, µÐ±â¼Õ»ó
  • closed injury
    Æó¼â¼Õ»ó
  • cold injury
    ÇÑ·©¼Õ»ó
  • concussive injury
    ÁøÅÁ¼Õ»ó
  • crush injury
    À¸±þ¼Õ»ó, ¾Ð±Ë¼Õ»ó
  • chemical injury
    È­ÇÐÀû¼Õ»ó
  • degloving injury
    ¹þ°ÜÁø¼Õ»ó
  • deceleration injury
    °¨¼Ó¼Õ»ó
  • extravasation injury
    Ç÷°ü¿ÜÀ¯Ãâ¼Õ»ó, Ç÷°ü¹Ù±ùÀ¯Ãâ¼Õ»ó
  • electrical injury
    Àü±â¼Õ»ó
  • flexion-extension injury
    ±ÁÈûÆï¼Õ»ó, ±¼½Å¼Õ»ó
  • gunshot injury
    ̄ȗ
  • hyperextension-hyperflexion injury
    °ú´ÙÆï±ÁÈû¼Õ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • good clinical practice
    ÀǾàǰÀÓ»ó½ÃÇè°ü¸®±âÁØ
  • structured clinical interview
    ±¸Á¶È­ÀÓ»ó¸éÁ¢
  • air-blast injury
    °ø±âÆø¾Ð¼Õ»ó, °ø±âÆØÃ¢¼Õ»ó
  • birth injury
    ºÐ¸¸¼Õ»ó
  • blast injury
    ÆøÇ³¼Õ»ó, ±â¾ÐÆøÇ³¼Õ»ó
  • blunt injury
    ¹«µò¼Õ»ó, µÐ±â¼Õ»ó
  • chemical injury
    È­ÇÐÀû¼Õ»ó
  • closed injury
    Æó¼â¼Õ»ó
  • cold injury
    ÇÑ·©¼Õ»ó
  • concussive injury
    ÁøÅÁ¼Õ»ó
  • crush injury
    À¸±þ¼Õ»ó, ¾Ð±Ë¼Õ»ó
  • crushing injury
    ¾Ð±Ë¼Õ»ó, ¢À̱è¼Õ»ó
  • injury control
    »óÇØ°ü¸®
  • degloving injury
    ¹þ°Ü±ä¼Õ»ó
  • electrical injury
    Àü±â¼Õ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • anterior spinal artery
    ¾Õô¼öµ¿¸Æ
  • anterior spinal artery syndrome
    Àüô¼öµ¿¸ÆÁõÈıº(¡­ñøý¦ÏØ).
  • anterior spinal sclerosis
    Àü»è°æÈ­Áõ(îñßãÌãûùñø).
  • anterior spinal syndrome
    Àü»èÁõÈıº(¡­ñøý¦ÏØ).
  • anterior spinal veins
    ¾Õô¼öÁ¤¸Æ
  • gray spinal syndrome
    ô¼öȸ»öÁúÁõÈıº(ô±âÐüéßäòõñøý¦ÏØ).
  • groove for spinal nerve
    ô¼ö½Å°æ°í¶û
  • hereditary spinal ataxia
    À¯Àü¼º ô¼ö¿îµ¿½ÇÁ¶(¡­ô±âÐê¡ÔÑã÷ðà).
  • hereditary spinal sclerosis
    À¯Àü¼º ô¼ö °æÈ­Áõ(¡­Ìãûùñø).
  • hereditary spinal sclerosis
    À¯Àü¼º ô¼ö°æÈ­Áõ(¡­Ìãûùñø).
  • high spinal anesthesia
    °íÀ§Ã´Ã߸¶Ãë(¹ý).
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
  • infantile spinal paralysis
    ¿µ¾ÆÃ´¼ö¼º ¸¶ºñ (?ä®ô±âÐàõØ«Ýö).
  • plexus of spinal nerves
    ô¼ö½Å°æ¾ó±â, ô¼ö½Å°æÃÑ(ô±âÐãêÌèõ¿).
  • plexus of spinal nerves
    ô¼ö½Å°æ¾ó±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • clinical isolate
    ÀÓ»óºÐ¸®ÁÖ
  • clinical laboratory
    ÀÓ»ó°Ë»ç½Ç
  • clinical manifestation
    ÀÓ»óÁõ»ó(¡­ñøßÒ).
  • clinical manifestation
    ÀÓ»óÀû Áõ»ó
  • clinical material
    Àӻ󰡰˹°, ÀÓ»ó°Ëü
  • clinical medicine
    ÀÓ»óÀÇÇÐ(¡­ì¢ùÊ).
  • clinical microbiology
    ÀÓ»ó¹Ì»ý¹°ÇÐ
  • clinical mycology
    ÀÓ»óÁø±ÕÇÐ
  • clinical neurophysiology
    ÀÓ»ó½Å°æ»ý¸®ÇÐ(ìúßÉãêÌèßæ×âùÊ)
  • clinical otosclerosis
    ¹ßÇö¼º À̰æÈ­Áõ
  • clinical pharmacology
    ÀÓ»ó¾à¸®ÇÐ.
  • clinical record
    ÀÓ»ó±â·Ï(¡­ÑÀÒÓ).
  • clinical root
    ÀÓ»óÄ¡¾Æ»Ñ¸®
  • clinical sign
    ÀÓ»ó¡ÈÄ.
  • clinical sign
    ÀÓ»óÀû ¡ÈÄ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SCC self-care center; sequential combination chemotherapy; services for crippled children; short-course ...
SCEP sandwich counterelectrophoresis; spinal cord evoked potential
Sp Cd, sp cd spinal cord
SSCCS slow spinal cord compression syndrome
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AIS Abbreviated Injury Score
ABI Acquired Brain Injury
ALI Acute Lung Injury
AI Axonal injury
BI Brain injury
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • injury potential
    ¼Õ»ó ÀüÀ§
  • intracranial injury
    µÎ°³³» ¼Õ»ó
  • neck injury
    °æºÎ ¿Ü»ó
  • non-injury controlled population
    ºñ¿Ü»ó¼º ȯÀÚ
  • ocular injury
    ´« ¿Ü»ó, ´«ÀÇ ¼Õ»ó
  • open injury
    °³¹æ¼º ¿Ü»ó, °³¹æ ¼Õ»ó, °³¹æ¼º ¼Õ»ó
  • past injury
    °ú°ÅÀÇ ¿Ü»ó
  • patterned injury
    º»¶á ¼Õ»ó
  • precipitating injury
    ÃËÁø ¼Õ»ó, ħ°­ ¼Õ»ó
  • regional injury
    ±¹ºÎ ¿Ü»ó
  • renal injury
    ½Å ¼Õ»ó
  • renal vascular injury
    ½Å Ç÷°ü ¼Õ»ó
  • rotator cuff injury
    ȸÀü ±Ù°³ ¼Õ»ó
  • sharp force injury
    ¿¹±â ¼Õ»ó
  • skin injury
    ÇǺΠ¼Õ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
injury potential The difference in potential recorded when one electrode is placed on intact nerve fibres or muscle fibres and the other electrode is placed on the injured ends of the same fibres; the intact portion is positive with reference to the injured portion.
Synonym: injury potential.
(05 Mar 2000)
injury severity score An anatomic severity scale based on the abbreviated injury scale (ais) and developed specifically to score multiple traumatic injuries. It has been used as a predictor of mortality.
(12 Dec 1998)
open head injury A head injury in which there is a loss of continuity of scalp or mucous membranes; the term is sometimes used to indicate a communication between the exterior and the intracranial cavity.
See: penetrating wound.
(05 Mar 2000)
egg-white injury <syndrome> Dermatitis, loss of hair, and loss of muscle coordination, produced in rats by diets containing large amounts of raw egg white, the avidin of which combines with biotin producing a deficiency of the latter.
Synonym: egg-white injury.
(05 Mar 2000)
Addison's clinical planes A series of plane's used as landmarks in thoracoabdominal topography; the trunk is divided vertically by a median plane from the upper border of the manubrium of the sternum to the pubic symphysis, by a lateral plane drawn vertically on either side through a point half way between the anterior superior iliac spine and the median plane at the interspinal plane, and by an interspinal plane passing vertically through the anterior superior iliac spine on either side; transversely the trunk is divided by a transthoracic plane passing across the thorax 3.2 cm above the lower border of the body of the sternum, by a transpyloric plane midway between the jugular notch of the sternum and the pubic symphysis, corresponding to the disc between the first and second lumbar vertebrae, and by an intertubercular plane passing through the iliac tubercles and cutting usually the fifth lumbar vertebra; the plane's formed on these lines, and also on transverse plane's cutting the upper edge of the manubrium and the upper edge of the pubic symphysis, constitute the clinical plane's of Addison.
(05 Mar 2000)
pathology, clinical A subspecialty of pathology which deals with the laboratory analysis of specimens of human blood and other fluids.
(12 Dec 1998)
chemistry, clinical The specialty of analytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy.
(12 Dec 1998)
pharmacology, clinical The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.
(12 Dec 1998)
phase I clinical trial <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose.
They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies.
The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs.
(31 Dec 1997)
phase II clinical trial <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study.
(31 Dec 1997)
phase III clinical trial <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments.
Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials.
(31 Dec 1997)
Millon clinical multiaxial inventory A paper and pencil test, consisting of 20 clinical scales derived from 175 self-descriptive statements, and developed in 1977 for use in the assessment of psychopathology and the more enduring patterns of personality; specifically designed to correspond with some of the disorders of personality included in the Diagnostic and Statistical Manual of Mental Disorders used in diagnosis by mental health professionals.
Synonym: Millon clinical multiaxial inventory.
(05 Mar 2000)
Millon Clinical Multiaxial Inventory test A paper and pencil test, consisting of 20 clinical scales derived from 175 self-descriptive statements, and developed in 1977 for use in the assessment of psychopathology and the more enduring patterns of personality; specifically designed to correspond with some of the disorders of personality included in the Diagnostic and Statistical Manual of Mental Disorders used in diagnosis by mental health professionals.
Synonym: Millon clinical multiaxial inventory.
(05 Mar 2000)
clinical 1. Pertaining to a clinic or to the bedside.
2. Pertaining to or founded on actual observation and treatment of patients, as distinguished from theoretical or basis sciences.
(18 Nov 1997)
clinical anatomy The practical application of anatomical knowledge to diagnosis and treatment.
Synonym: applied anatomy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á